• LAST PRICE
    32.9400
  • TODAY'S CHANGE (%)
    Trending Down-0.3700 (-1.1108%)
  • Bid / Lots
    30.0000/ 5
  • Ask / Lots
    34.1400/ 1
  • Open / Previous Close
    33.0700 / 33.3100
  • Day Range
    Low 30.7500
    High 34.0760
  • 52 Week Range
    Low 29.5000
    High 78.0000
  • Volume
    421,062
    average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Line Graph See accessible table below
News Volume Accessibility Table
DateIndex Fund Price vs. News Density
11/3$54.82
11/4$54.49
11/5$53.78
11/8$52.02
11/9$49.90
11/10$49.30
11/11$48.57
11/12$48.27
11/15$46.00
11/16$44.97
11/17$41.39
11/18$41.28
11/19$41.30
11/22$38.53
11/23$35.06
11/24$35.74
11/26$33.15
11/29$33.25
11/30$34.08
12/1$33.31
12/2$32.94

9:32AM ET on Monday Nov 29, 2021 by MT Newswires
Companies Mentioned: VERV, VYGR
09:32 AM EST, 11/29/2021 (MT Newswires) -- Verve Therapeutics (VERV) on Monday said that Allison Dorval has been named as chief financial officer. Dorval joins Verve from Voyager Therapeutics (VYGR), according to a statement. Price: 32.32, Change: -...

8:08AM ET on Monday Nov 29, 2021 by GlobeNewswire
Companies Mentioned: VERV

Verve Therapeutics, Inc., (Nasdaq: VERV), a biotech company pioneering a new approach to the care of cardiovascular disease with single-course gene editing medicines, today announced that Allison Dorval has been appointed as chief financial officer. Ms. Dorval joins Verve from Voyager Therapeutics and brings more than 20 years of leadership experience in finance, accounting, financial reporting and investor relations.

8:04AM ET on Monday Nov 29, 2021 by Thomson Reuters
Companies Mentioned: VERV

Nov 29 (Reuters) - Verve Therapeutics Inc:

* VERVE THERAPEUTICS APPOINTS ALLISON DORVAL, EXPERIENCED FINANCIAL EXECUTIVE, AS CHIEF FINANCIAL OFFICER So...

7:51AM ET on Wednesday Nov 10, 2021 by MT Newswires
Companies Mentioned: VERV
07:51 AM EST, 11/10/2021 (MT Newswires) -- Verve Therapeutics, Inc. (VERV) on Wednesday reported a Q3 net loss of $0.47 per share, compared with a loss of $3.81 per share in the year-earlier quarter. One analysts polled by Capital IQ expected a loss...

6:40AM ET on Wednesday Nov 10, 2021 by Thomson Reuters
Companies Mentioned: VERV

Nov 10 (Reuters) - Verve Therapeutics Inc:

* VERVE THERAPEUTICS ANNOUNCES PIPELINE PROGRESS AND REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS

* Q3 LOSS P...

Peers Headlines

Yesterday

Dec 1, 2021

3:37AM ET on Wednesday Dec 01, 2021 by MT Newswires
Companies Mentioned: KRYS

Nov 30, 2021

8:17PM ET on Tuesday Nov 30, 2021 by Thomson Reuters
Companies Mentioned: KRYS

8:15PM ET on Tuesday Nov 30, 2021 by GlobeNewswire
Companies Mentioned: KRYS

4:06PM ET on Tuesday Nov 30, 2021 by MT Newswires
Companies Mentioned: ATRA

Nov 29, 2021

4:53PM ET on Monday Nov 29, 2021 by MT Newswires
Companies Mentioned: KRYS

4:24PM ET on Monday Nov 29, 2021 by Thomson Reuters
Companies Mentioned: KRYS

4:20PM ET on Monday Nov 29, 2021 by GlobeNewswire
Companies Mentioned: KRYS